Salts And Crystalline Forms Of An Apoptosis-Inducing Agent
Patent No. EP2643322 (titled "Salts And Crystalline Forms Of An Apoptosis-Inducing Agent") was filed by Abbvie on Nov 21, 2011. The application was issued on Aug 30, 2017.
Patent Summary
Patent Family
Patent Oppositions
Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.
Dossier Documents
The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.
Date
Description
Get instant alerts for new documents
EP2643322
- Application Number
- EP11791401A
- Filing Date
- Nov 21, 2011
- Status
- Revoked
- Sep 24, 2019
- Publication Date
- Aug 30, 2017
- External Links
- Slate, Register , Google Patents